NOD-like receptors (NLRs) are a family of intracellular sensor molecules involved in the regulation of inflammatory signaling in response to infection and cellular stress. Recent studies have revealed pivotal roles for NLR-mediated inflammation in a spectrum of diverse human autoimmune and inflammatory disorders. The vast majority of NLRs to date have been defined as activators of inflammatory signaling in innate immune cells. For instance, the prototypical NLR members, NOD1 and NOD2, initiate proinflammatory NF-?B and MAPK signaling in response to their direct recognition of bacterial peptidoglycan fragments. Multiple NLRs have also been described to promote the activation and secretion of the proinflammatory cytokines IL-1? and IL-18 by coordinating the assembly of the inflammasome complex. In contrast, some NLRs, such as NLRP6, NLRP12, NLRC3 and NLRX1, negatively regulate inflammatory signaling. However, the cellular and molecular mechanisms that direct the suppression of inflammation by this new class of inhibitory NLRs are not known. Missense mutations in NLRP12 are associated with inflammatory diseases in humans, but the biochemical mechanisms and pathways underlying these pathologies remain unclear. Recent work from our lab demonstrates that NLRP12 functions as a key negative regulator of NF-?B signaling. Importantly, inflammation and immunopathology are not exclusively restricted to inflammatory and autoimmune diseases. The dysregulation of innate and adaptive immunity can also result in striking differences with regard to morbidity and mortality during infectious disease. In this regard, NLRP12's role in viral infection and generation of adaptive immune responses has not been investigated. Therefore, this project is highly significant, as it will lead to the identification of key immune mechanisms involved in host defense and inflammatory control mechanisms dependent on NLRP12 that regulate inflammation. We will examine these mechanisms through the use of influenza A virus.

Public Health Relevance

Missense mutations in Nlrp12 lead to inflammatory diseases in humans. The studies proposed in this application on the signaling pathways involved in innate and acquired host immune responses, regulated by NLRP12 will increase our understanding of key regulators of immunity and host defense that operate in major human diseases. These studies uncover novel signaling pathways that will help in the design of therapeutics to treat infectious and inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI124346-05
Application #
9872119
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Vazquez-Maldonado, Nancy
Project Start
2016-03-15
Project End
2021-02-28
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) ZBP1: Innate Sensor Regulating Cell Death and Inflammation. Trends Immunol 39:123-134
Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease? Circulation 138:2662-2665
Zhu, Qifan; Man, Si Ming; Karki, Rajendra et al. (2018) Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection. Cell Rep 22:3168-3174
Balakrishnan, Arjun; Karki, Rajendra; Berwin, Brent et al. (2018) Guanylate binding proteins facilitate caspase-11-dependent pyroptosis in response to type 3 secretion system-negative Pseudomonas aeruginosa. Cell Death Discov 4:3
Tartey, Sarang; Gurung, Prajwal; Dasari, Tejasvi Krishna et al. (2018) ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis. J Clin Invest 128:2042-2047
Karki, Rajendra; Lee, Ein; Place, David et al. (2018) IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. Cell 173:920-933.e13
Malireddi, R K Subbarao; Gurung, Prajwal; Mavuluri, Jayadev et al. (2018) TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med 215:1023-1034
Sharma, Deepika; Malik, Ankit; Guy, Clifford S et al. (2018) Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. Gastroenterology 154:948-964.e8
Malik, Ankit; Kanneganti, Thirumala-Devi (2018) Function and regulation of IL-1? in inflammatory diseases and cancer. Immunol Rev 281:124-137
Place, David E; Kanneganti, Thirumala-Devi (2018) Recent advances in inflammasome biology. Curr Opin Immunol 50:32-38

Showing the most recent 10 out of 39 publications